How has the UK compared to its European peers in terms of supporting growth and innovation in the pharmaceutical sector? And with a renegotiation of the PPRS pricing deal imminent, Leela Barha
The UK pharmaceutical industry is mounting a legal challenge to NICE and NHS England in court – but the credibility of one of its key witnesses has been called into question.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.